These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 17878391)

  • 1. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
    Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
    J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.
    Alvarez-Fernández C; Escribà-Garcia L; Vidal S; Sierra J; Briones J
    J Transl Med; 2016 Jul; 14(1):214. PubMed ID: 27435312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient stimulation expands superior antitumor T cells for adoptive therapy.
    Kagoya Y; Nakatsugawa M; Ochi T; Cen Y; Guo T; Anczurowski M; Saso K; Butler MO; Hirano N
    JCI Insight; 2017 Jan; 2(2):e89580. PubMed ID: 28138559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of a cell based artificial antigen-presenting cell for expansion and activation of CD8+ T cells ex vivo.
    Gong W; Ji M; Cao Z; Wang L; Qian Y; Hu M; Qian L; Pan X
    Cell Mol Immunol; 2008 Feb; 5(1):47-53. PubMed ID: 18318994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.
    Kim YJ; Brutkiewicz RR; Broxmeyer HE
    Blood; 2002 Nov; 100(9):3253-60. PubMed ID: 12384425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.
    Bertram EM; Dawicki W; Sedgmen B; Bramson JL; Lynch DH; Watts TH
    J Immunol; 2004 Jan; 172(2):981-8. PubMed ID: 14707071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.
    Hernandez-Chacon JA; Li Y; Wu RC; Bernatchez C; Wang Y; Weber JS; Hwu P; Radvanyi LG
    J Immunother; 2011 Apr; 34(3):236-50. PubMed ID: 21389874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor expression of 4-1BB ligand sustains tumor lytic T cells.
    Zhang H; Merchant MS; Chua KS; Khanna C; Helman LJ; Telford B; Ward Y; Summers J; Toretsky J; Thomas EK; June CH; Mackall CL
    Cancer Biol Ther; 2003; 2(5):579-86. PubMed ID: 14614331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    Wen T; Bukczynski J; Watts TH
    J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.
    Maus MV; Thomas AK; Leonard DG; Allman D; Addya K; Schlienger K; Riley JL; June CH
    Nat Biotechnol; 2002 Feb; 20(2):143-8. PubMed ID: 11821859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.
    Saoulli K; Lee SY; Cannons JL; Yeh WC; Santana A; Goldstein MD; Bangia N; DeBenedette MA; Mak TW; Choi Y; Watts TH
    J Exp Med; 1998 Jun; 187(11):1849-62. PubMed ID: 9607925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in lymphocytes' telomerase activity by 4-1BB costimulation.
    Ahmad HT; Mansooreh J; Fereshteh M; Mojtaba H
    J Cancer Res Ther; 2014; 10(4):998-1003. PubMed ID: 25579543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.
    Markiewicz MA; Carayannopoulos LN; Naidenko OV; Matsui K; Burack WR; Wise EL; Fremont DH; Allen PM; Yokoyama WM; Colonna M; Shaw AS
    J Immunol; 2005 Sep; 175(5):2825-33. PubMed ID: 16116168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway.
    Diehl L; van Mierlo GJ; den Boer AT; van der Voort E; Fransen M; van Bostelen L; Krimpenfort P; Melief CJ; Mittler R; Toes RE; Offringa R
    J Immunol; 2002 Apr; 168(8):3755-62. PubMed ID: 11937526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.
    Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    J Immunol; 2002 Nov; 169(10):5780-6. PubMed ID: 12421958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.
    Rudolf D; Silberzahn T; Walter S; Maurer D; Engelhard J; Wernet D; Bühring HJ; Jung G; Kwon BS; Rammensee HG; Stevanović S
    Cancer Immunol Immunother; 2008 Feb; 57(2):175-83. PubMed ID: 17657490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.
    Bertram EM; Lau P; Watts TH
    J Immunol; 2002 Apr; 168(8):3777-85. PubMed ID: 11937529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 co-stimulation via tumour-specific chimaeric receptors induces an incomplete activation response in Epstein-Barr virus-specific effector memory T cells.
    Altvater B; Pscherer S; Landmeier S; Niggemeier V; Juergens H; Vormoor J; Rossig C
    Clin Exp Immunol; 2006 Jun; 144(3):447-57. PubMed ID: 16734614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.